>>Magnus  Product Range


MAGNUS SHIELD™ prostate formula contains Standardized Flower Pollen Extract G60 and GBX that have been used successfully over past 50 years in America and Europe for Prostate treatment. Flower pollen is the male seed of flowers which enables flowering plants to reproduce. It is produced in the upper part, or anthers, of the flower. Pollen grains contain all the substances that are necessary to create new life within the world of plants. Like a sparkle of energy, creating new life is still a secret to us.

Flower Pollen has a number of physiological effects that could benefit BPH. It has an anticongenstive-antiinflammatory action which could lessen external pressure on the urethra. Additionally Pharmacological effects reported for the pollen preparation are: influence on contactility of bladder, and influence on the metabolism of dihydrotestosterone.

MAGNUS PRIME™ supports the body’s prostate gland and urinary system function through the benefits of SP63™.  SP63™ is a combination of Cernitin™ Standardized Flower Pollen Extract (a synergistic combination of over 39 vitamins, minerals, and caretenoids, 23 essential and non-essential amino acids, 98 enzymes, polar and neutral lipids, 20 fatty acids, prostaglandins, phytosterols, and long chain hydrocarbons), and Standardized Saw Palmetto Extract (Serenoa Repens).

Saw Palmetto (Serenoa repens) is an extract of the pulp and seeds of a dwarf, scrubby palm tree native to the west Indies and the Atlantic coast of the United States. It is generally accepted that Saw Palmetto works, at lest in part, by the same major mechanism as finasteride (PROSCAR), i.e., preventing the conversion of testosterone to DHT. However, Saw Palmetto not only lowers the rate of DHT formation, but blocks the ability of DHT to bind to cells, preventing the action of hormone on receptors. In addition, it may prevent severe inflammatory responses via a dose related effect on the arachidonic acid cascade through a double blocking of cyclo-oxygenase and lipoxygenase pathways. In one study examining 110 subjects, it decreased night time urination by 45%, increased urinary flow rate more than 50%, and reduced the amount of urine left in the bladder after urination by 42%. In other large trials, improvement in prostatic symptomatology was readily noted and saw palmetto even compared favorable with Hytric (Alpha blocker) and/or Proscar (finasteride) in affecting the symptomatology of BPH when these agents were compared head to head.

Therefore, we conclude that Magnus Shield and Magnus Prime have been clinically proven to assist with management and symptomatic relief of medically diagnosed Enlarged Prostate or commonly known as Benign Prostatic Hypertrophy, Nocturia (Frequent Urination) and Cronic Prostatitis.


Click here to view Clinical Studies


© Copyright 2006 Graminex Australia Pty. Ltd. All Rights reserved.